Advanced in Chronic Familial Neutropenia

Dr. Malcolm S. Trimble

Hematology Oncology | Hematology
W A Foote Memorial Hospital Inc
1100 E Michigan Ave, 307 Henry Ford Allegiance, 
Jackson, MI 
Accepting New Patients
Advanced in Chronic Familial Neutropenia
W A Foote Memorial Hospital Inc
1100 E Michigan Ave, 307 Henry Ford Allegiance, 
Jackson, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Malcolm Trimble is a Hematologist Oncology specialist and a Hematologist in Jackson, Michigan. Dr. Trimble is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. His top areas of expertise are Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Lymphofollicular Hyperplasia. Dr. Trimble is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Licenses
Internal Medicine in MI
Hospital Affiliations
Henry Ford Allegiance Health
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

W A FOOTE MEMORIAL HOSPITAL INC
1100 E Michigan Ave, 307 Henry Ford Allegiance, Jackson, MI 49201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drugs: RRx-001, Cisplatin, Etoposide, Carboplatin, Irinotecan, Vinorelbine, Doxil, Gemcitabine, Taxane, Paclitaxel, Nab-Paclitaxel, Pemetrexed
Study Phase: Phase 2
A Phase 1 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (BRAINSTORM)
A Phase 1 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (BRAINSTORM)
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Drug: RRx-001
Study Phase: Phase 1
View 1 Less Clinical Trial

1 Total Publications

BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases.
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases.
Journal: International journal of radiation oncology, biology, physics
Published: August 22, 2019
Similar Doctors
Distinguished in Chronic Familial Neutropenia
Dr. Mohammed K. Ibrahim
Hematology Oncology | Hematology | Oncology
Distinguished in Chronic Familial Neutropenia
Dr. Mohammed K. Ibrahim
Hematology Oncology | Hematology | Oncology

Michigan Healthcare Professionals PC

27900 Grand River Ave, 
Farmington Hills, MI 
 (56.2 miles away)
Languages Spoken:
English, Hindi, Tamil, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Mohammed Ibrahim is a Hematologist Oncology specialist and a Hematologist in Farmington Hills, Michigan. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Chronic Familial Neutropenia. His top areas of expertise are Agranulocytosis, Chronic Familial Neutropenia, Thrombocytopenia, Vitamin B12 Deficiency, and Bone Marrow Aspiration. Dr. Ibrahim is currently accepting new patients.

Distinguished in Chronic Familial Neutropenia
Dr. Martin G. Tapia
Hematology Oncology | Hematology | Oncology
Distinguished in Chronic Familial Neutropenia
Dr. Martin G. Tapia
Hematology Oncology | Hematology | Oncology

Michigan Healthcare Professionals PC

6770 Dixie Hwy, Suite 106a, 
Clarkston, MI 
 (59.2 miles away)
248-288-4500
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Martin Tapia is a Hematologist Oncology specialist and a Hematologist in Clarkston, Michigan. Dr. Tapia is rated as a Distinguished provider by MediFind in the treatment of Chronic Familial Neutropenia. His top areas of expertise are Severe Congenital Neutropenia, Chronic Familial Neutropenia, Agranulocytosis, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Tapia is currently accepting new patients.

Distinguished in Chronic Familial Neutropenia
Dr. Muhammad Y. Hamdan
Hematology Oncology | Oncology | Hematology
Distinguished in Chronic Familial Neutropenia
Dr. Muhammad Y. Hamdan
Hematology Oncology | Oncology | Hematology

Sparrow Ionia Hospital

3565 S State Rd, 
Ionia, MI 
 (58.5 miles away)
616-523-1600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Muhammad Hamdan is a Hematologist Oncology specialist and an Oncologist in Ionia, Michigan. Dr. Hamdan is rated as a Distinguished provider by MediFind in the treatment of Chronic Familial Neutropenia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Hamdan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Trimble's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 47 Advanced Conditions
    View All 88 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile